Study That Tests AD109 in Patients Taking GLP-1 Drugs
Study sponsor: Apnimed
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-12-26Actual
Enrollment · participants40Actual
Source updated2025-02-19Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.